Synlait Milk Maps Three-Phase Recovery After $64M EBITDA Masks Deeper Losses
Synlait Milk unveils ‘Stabilise, Simplify, Scale’ recovery roadmap after challenging half
Synlait Milk (ASX: SM1) has released its recovery roadmap following a difficult first half of FY26, outlining a phased turnaround strategy as it prepares to complete the sale of its North Island assets next week. The dairy processor reported EBITDA of $64.4 million (up 88%) despite posting a headline net loss, signalling underlying operational improvement amid a period management described as a “perfect storm” of compounding challenges.
Total group revenue reached $949.0 million for the six months ended 31 January 2026, while operating cash flow turned positive at $32.2 million compared to negative $27.3 million in the prior corresponding period. Net debt stood at $472.1 million, increased from $171.3 million at the end of FY25. Chair George Adams and CEO Richard Wyeth emphasised that the half-year result reflects circumstantial issues rather than the company’s future trajectory.
When big ASX news breaks, our subscribers know first
What caused the ‘perfect storm’ in HY26?
Management attributed the disappointing financial outcome to a sequence of five interconnected challenges that compounded throughout the period. The company has provided transparency around the cause-and-effect chain that shaped its first-half performance.
- Manufacturing challenges in the second half of FY25 created an inventory shortfall, requiring customer inventory rebuilding.
- Synlait adjusted its manufacturing plan to enable production teams to focus on catch-up production for key customers.
- The revised plan resulted in surplus milk during peak season, which Synlait sold tactically to manage the excess.
- When several milk sales fell through, Synlait’s Dunsandel teams were forced to pause catch-up production and process the unsold milk, with dryer configurations limiting production to whole milk powder (WMP).
- Global WMP prices decreased sharply in late 2025, resulting in significant losses in the Ingredients portfolio.
CEO Richard Wyeth stated: “It was a lack of viable choices that shaped Synlait’s first half performance. At every stage, your Board and executive leadership team carefully analysed, costed, and weighed up our limited options.” The company noted that even with hindsight, alternative approaches would have delivered similar outcomes due to the lack of commercial optionality.
Understanding dairy processor ‘optionality’ and why it matters
Commercial optionality in dairy processing refers to having multiple viable pathways for raw milk, including different products, customers, or sales channels. A processor with strong optionality can pivot between manufacturing infant formula, nutritional powders, cheese, or commodity ingredients depending on market conditions and customer demand.
Synlait’s lack of optionality during HY26 forced the business into suboptimal decisions. When planned milk sales collapsed and dryer configurations limited production choices, the company had no alternative but to manufacture WMP precisely when global prices were declining. Building optionality has become a stated management priority for the recovery phase.
For investors, this concept is central to understanding the turnaround thesis. A dairy processor with diverse product pathways and customer relationships can mitigate exposure to single-product downturns, reducing earnings volatility and improving capital efficiency over time.
The three-horizon recovery plan taking shape
The Stabilise, Simplify, Scale framework represents management’s phased approach to repositioning the business. Chair George Adams emphasised a commitment to “under promise and over deliver” over the next 12 to 24 months, signalling realistic expectations rather than aggressive near-term targets.
| Horizon | Focus | Key Actions |
|---|---|---|
| Stabilise | Operational stability | Meet customer expectations, strengthen balance sheet via North Island sale, build greater optionality |
| Simplify | Transformation | Align priorities, sharpen capability, grow high-margin products from existing assets to lift profitability |
| Scale | Growth acceleration | Expand markets, channels, and customers; execute future growth opportunities |
The North Island asset sale to Abbott is expected to strengthen Synlait’s balance sheet whilst removing loss-making operations. A third-party manufacturing agreement has been secured with Abbott for the production of certain base powders following completion. The phased structure indicates management is prioritising operational foundation-building before pursuing growth investments.
Leadership refresh and operational progress
Synlait has appointed Chief Operating Officer Rich Hickson (joined February 2026) and Chief Revenue Officer Hamish Yates (joined December 2025), both bringing operational transformation track records to the renewed executive leadership team. The entire ELT is now based in Canterbury, positioning leadership closer to core manufacturing operations at Dunsandel.
Chief Quality Officer Hila Mory has delivered a new Quality Strategy, overhauling the operating model from policy settings and training through to environmental controls and hygiene practices. The company reported measurable improvements across all core quality metrics following the launch of the Synlait Care initiative.
The closure of the Palmerston North facility is estimated to deliver cost savings exceeding $2 million per year going forward. Management has reset the company-wide learning and development training programme with a specific focus on operational teams, aligning employee experience with performance expectations.
Farmer returns and milk supply stability
Synlait has outlined its forecast FY26 milk price structure, targeting competitive returns to secure milk supply in the Canterbury market.
- Base milk price: $9.50 per kilogram of milk solids
- Average Synlait milk incentive: $0.30 per kilogram of milk solids (comprising Lead With Pride, Winter Milk, a2 and customer sustainability premiums)
- Synlait Secured Milk Premium: $0.10 per kilogram of milk solids (for farmers committed to supply without a cease notice through FY26, FY27 and FY28)
- Total forecast average payment: $9.90 per kilogram of milk solids
The premium structure is designed to reward farmer commitment whilst providing supply certainty during the stabilisation phase. Competitive milk pricing remains essential for securing raw material supply in a market where farmers have alternative processing options.
The next major ASX story will hit our subscribers first
What to watch in the second half
The Board has withdrawn financial guidance for the remainder of FY26, reflecting near-term uncertainty whilst the turnaround strategy is implemented. An insurance claim is expected to recover a portion of losses incurred from FY25 manufacturing challenges, with further updates to follow once details are confirmed.
The transition of The a2 Milk Company’s English-label a2 Platinum production to their Pōkeno facility will free up manufacturing capacity at Dunsandel, creating opportunities for new customer relationships. Synlait remains committed to supporting The a2 Milk Company’s China-label product, which is registered for manufacture at the Dunsandel facility.
Richard Wyeth, CEO
“Improving Synlait’s commercial optionality is a critical focus for our future.”
Management stated it will only consider further growth opportunities once confident the business is positioned to fund and deliver them. The immediate focus remains on building additional commercial optionality and optimising existing assets before pursuing expansion. For investors, the roadmap provides a framework for measuring execution over the next 12 to 24 months as the company works to restore financial performance.
Don’t Miss the Next Consumer Staples Breakout
Join 20,000+ investors getting FREE breaking ASX news delivered to your inbox within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at Big News Blast to start receiving alerts the moment market-moving announcements hit the ASX across Consumer, Tech, Healthcare, Finance and more.